MetLife Investment Management, LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 199 filers reported holding IMMUNOGEN INC in Q2 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$2,029,678
-15.9%
127,8940.0%0.02%
-11.1%
Q2 2023$2,413,360
+469.0%
127,894
+15.8%
0.02%
+500.0%
Q1 2023$424,104
-22.6%
110,4440.0%0.00%
-25.0%
Q4 2022$547,802
+3.8%
110,4440.0%0.00%
-20.0%
Q3 2022$527,922
+16.4%
110,444
+9.6%
0.01%
+25.0%
Q2 2022$453,497
-12.2%
100,777
-7.1%
0.00%
+33.3%
Q1 2022$516,346
-0.3%
108,476
+55.4%
0.00%
-25.0%
Q4 2021$517,894
+54.2%
69,797
+17.8%
0.00%
+33.3%
Q3 2021$335,896
-30.8%
59,241
-19.6%
0.00%
-40.0%
Q2 2021$485,670
-18.6%
73,6980.0%0.01%
-16.7%
Q1 2021$596,954
+56.0%
73,698
+24.2%
0.01%
+50.0%
Q4 2020$382,691
+89.8%
59,332
+5.9%
0.00%
+100.0%
Q3 2020$201,604
-43.4%
56,001
-27.7%
0.00%
-50.0%
Q2 2020$356,500
+34.9%
77,5000.0%0.00%0.0%
Q1 2020$264,275
-13.4%
77,500
+29.7%
0.00%
+33.3%
Q4 2019$305,003
+111.0%
59,7460.0%0.00%
+50.0%
Q3 2019$144,585
+11.5%
59,7460.0%0.00%
+100.0%
Q2 2019$129,649
-19.9%
59,7460.0%0.00%
-50.0%
Q1 2019$161,912
-43.5%
59,7460.0%0.00%
-50.0%
Q4 2018$286,781
-49.3%
59,7460.0%0.00%
-33.3%
Q3 2018$565,795
-2.6%
59,7460.0%0.01%
-14.3%
Q2 2018$581,000
+20.0%
59,746
+29.8%
0.01%
+16.7%
Q1 2018$484,000
+64.1%
46,0190.0%0.01%
+100.0%
Q4 2017$295,00046,0190.00%
Other shareholders
IMMUNOGEN INC shareholders Q2 2018
NameSharesValueWeighting ↓
Redmile Group, LLC 13,063,767$35,403,0001.04%
QVT Financial LP 1,375,900$3,442,0000.87%
Virtus ETF Advisers LLC 50,045$136,0000.29%
Fernwood Investment Management, LLC 187,000$507,0000.27%
PURA VIDA INVESTMENTS, LLC 524,600$1,422,0000.20%
Endurant Capital Management LP 184,440$500,0000.20%
Birchview Capital, LP 90,000$244,0000.15%
TWIN FOCUS CAPITAL PARTNERS, LLC 112,873$306,0000.14%
DLD Asset Management, LP 1,239,500$3,347,0000.12%
DLD Asset Management, LP 1,186,300$3,215,0000.12%
View complete list of IMMUNOGEN INC shareholders